Publications by authors named "Junlin Dong"

Claim this Profile
C
Carrier-free nanoparticles based on natural products trigger dual "synergy and attenuation" for enhanced phototherapy of liver cancer.
Xiongqin Wang, Kunhui Sun, Junlin Dong, Yanli Ge, Haifan Liu

Mater Today Bio· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanocarriers based therapy and diagnosis of brain diseases: cross the blood-brain barrier.
Lijun An, Jinwei Zhang, Xiaobo Wang, Yuanyuan Ge, Kunhui Sun, Junlin Dong

Sci Technol Adv Mater· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood-brain barrier permeability.
Suyi Liu, Xingyue Jin, Yuanyuan Ge, Junlin Dong, Xinyue Liu

J Nanobiotechnology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma.
Linhua Liu, Bing Wang, Yibo Ma, Kunhui Sun, Ping Wang, Junlin Dong

Front Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Deciphered Molecular Mechanistics with Accurate Kinetic and Thermodynamic Prediction.
Junlin Dong, Shiyu Wang, Wenqiang Cui, Xiaolin Sun, Haojie Guo

J Chem Theory Comput· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning for data-driven design of high-safety lithium metal anode.
Qi Zhang, Junlin Dong, Chuan Zhou, Dantong Zhang, Shuguang Yuan, Dongfeng Xue

STAR Protoc· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The structure and function of olfactory receptors.
Chenyang Wu, Marc Xu, Junlin Dong, Wenqiang Cui, Shuguang Yuan

Trends Pharmacol Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational drug development for membrane protein targets.
Haijian Li, Xiaolin Sun, Wenqiang Cui, Marc Xu, Junlin Dong, Dongchun Ni

Nat Biotechnol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis of ligand selectivity for melatonin receptors.
Wenqiang Cui, Junlin Dong, Shiyu Wang, Horst Vogel, Rongfeng Zou

RSC Adv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2.
Ke Liu, Rongfeng Zou, Wenqiang Cui, Meiqing Li, Xueying Wang, Junlin Dong

ACS Pharmacol Transl Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy.
Hanguang Ruan, Junlin Dong, Xueliang Zhou, Juan Xiong, Hua Wang

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis